Multivariate models to detect genomic signatures for a class of drugs: Application to thiopurines pharmacogenomics

B. L. Fridley, G. D. Jenkins, A. Batzler, Liewei M Wang, Y. Ji, F. Li, Richard M Weinshilboum

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Often, analysis for pharmacogenomic studies involving multiple drugs from the same class is completed by analyzing each drug individually for association with genomic variation. However, by completing the analysis of each drug individually, we may be losing valuable information. When studying multiple drugs from the same drug class, one may wish to determine genomic variation that explains the difference in response between individuals for the drug class, as opposed to each individual drug. Therefore, we have developed a multivariate model to assess whether genomic variation impacts a class of drugs. In addition to determine genomic effects that are similar for the drugs, we will also be able to determine genomic effects that differ between the drugs (that is, interaction). We will illustrate the utility of this multivariate model for cytotoxicity and genomic data collected on the Coriell Human Variation Panel for the class of anti-purine metabolites (6-mercaptopurine and 6-thioguanine).

Original languageEnglish (US)
Pages (from-to)105-110
Number of pages6
JournalPharmacogenomics Journal
Volume12
Issue number2
DOIs
StatePublished - Apr 2012

Fingerprint

Pharmacogenetics
Pharmaceutical Preparations
Thioguanine
6-Mercaptopurine
Drug Interactions

Keywords

  • class of drugs
  • cytotoxicity
  • mRNA expression data
  • statistical analysis
  • thiopurines

ASJC Scopus subject areas

  • Pharmacology
  • Molecular Medicine
  • Genetics

Cite this

Multivariate models to detect genomic signatures for a class of drugs : Application to thiopurines pharmacogenomics. / Fridley, B. L.; Jenkins, G. D.; Batzler, A.; Wang, Liewei M; Ji, Y.; Li, F.; Weinshilboum, Richard M.

In: Pharmacogenomics Journal, Vol. 12, No. 2, 04.2012, p. 105-110.

Research output: Contribution to journalArticle

@article{68b73eddf9d84df191f390c3a6b46cfa,
title = "Multivariate models to detect genomic signatures for a class of drugs: Application to thiopurines pharmacogenomics",
abstract = "Often, analysis for pharmacogenomic studies involving multiple drugs from the same class is completed by analyzing each drug individually for association with genomic variation. However, by completing the analysis of each drug individually, we may be losing valuable information. When studying multiple drugs from the same drug class, one may wish to determine genomic variation that explains the difference in response between individuals for the drug class, as opposed to each individual drug. Therefore, we have developed a multivariate model to assess whether genomic variation impacts a class of drugs. In addition to determine genomic effects that are similar for the drugs, we will also be able to determine genomic effects that differ between the drugs (that is, interaction). We will illustrate the utility of this multivariate model for cytotoxicity and genomic data collected on the Coriell Human Variation Panel for the class of anti-purine metabolites (6-mercaptopurine and 6-thioguanine).",
keywords = "class of drugs, cytotoxicity, mRNA expression data, statistical analysis, thiopurines",
author = "Fridley, {B. L.} and Jenkins, {G. D.} and A. Batzler and Wang, {Liewei M} and Y. Ji and F. Li and Weinshilboum, {Richard M}",
year = "2012",
month = "4",
doi = "10.1038/tpj.2010.83",
language = "English (US)",
volume = "12",
pages = "105--110",
journal = "Pharmacogenomics Journal",
issn = "1470-269X",
publisher = "Nature Publishing Group",
number = "2",

}

TY - JOUR

T1 - Multivariate models to detect genomic signatures for a class of drugs

T2 - Application to thiopurines pharmacogenomics

AU - Fridley, B. L.

AU - Jenkins, G. D.

AU - Batzler, A.

AU - Wang, Liewei M

AU - Ji, Y.

AU - Li, F.

AU - Weinshilboum, Richard M

PY - 2012/4

Y1 - 2012/4

N2 - Often, analysis for pharmacogenomic studies involving multiple drugs from the same class is completed by analyzing each drug individually for association with genomic variation. However, by completing the analysis of each drug individually, we may be losing valuable information. When studying multiple drugs from the same drug class, one may wish to determine genomic variation that explains the difference in response between individuals for the drug class, as opposed to each individual drug. Therefore, we have developed a multivariate model to assess whether genomic variation impacts a class of drugs. In addition to determine genomic effects that are similar for the drugs, we will also be able to determine genomic effects that differ between the drugs (that is, interaction). We will illustrate the utility of this multivariate model for cytotoxicity and genomic data collected on the Coriell Human Variation Panel for the class of anti-purine metabolites (6-mercaptopurine and 6-thioguanine).

AB - Often, analysis for pharmacogenomic studies involving multiple drugs from the same class is completed by analyzing each drug individually for association with genomic variation. However, by completing the analysis of each drug individually, we may be losing valuable information. When studying multiple drugs from the same drug class, one may wish to determine genomic variation that explains the difference in response between individuals for the drug class, as opposed to each individual drug. Therefore, we have developed a multivariate model to assess whether genomic variation impacts a class of drugs. In addition to determine genomic effects that are similar for the drugs, we will also be able to determine genomic effects that differ between the drugs (that is, interaction). We will illustrate the utility of this multivariate model for cytotoxicity and genomic data collected on the Coriell Human Variation Panel for the class of anti-purine metabolites (6-mercaptopurine and 6-thioguanine).

KW - class of drugs

KW - cytotoxicity

KW - mRNA expression data

KW - statistical analysis

KW - thiopurines

UR - http://www.scopus.com/inward/record.url?scp=84859001880&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859001880&partnerID=8YFLogxK

U2 - 10.1038/tpj.2010.83

DO - 10.1038/tpj.2010.83

M3 - Article

C2 - 21060324

AN - SCOPUS:84859001880

VL - 12

SP - 105

EP - 110

JO - Pharmacogenomics Journal

JF - Pharmacogenomics Journal

SN - 1470-269X

IS - 2

ER -